Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo.
Bruyère C, Abeloos L, Lamoral-Theys D, Senetta R, Mathieu V, Le Mercier M, Kast RE, Cassoni P, Vandenbussche G, Kiss R, et al. Transl Oncol. 2011 Apr 1; 4(2):92-100. Epub 2011 Apr 1.